Dr. Mansour Gergi, MD

Dr. Gergi practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Dr. Gergi's NPI, 1861843963, was assigned on June 29, 2016. Dr. Gergi graduated from Lebanese University School of Medicine in 2015. Dr. Gergi holds Vermont license 042-0015734.

Dr. Gergi's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Dr. Gergi's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Dr. Gergi is also affiliated with Champlain Valley Physicians Hospital. The medical group on file is University of Vermont Medical Center. Dmand AI also links Dr. Gergi to 3 more hospitals and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gergi practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Gergi's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Gergi's licenses on file in 2 states: Vermont and Rhode Island.

CMS data shows 554 Medicare services from Dr. Gergi across 8 procedure codes in 2024, for 281 Medicare patients. Medicare paid $48,070 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 281 Medicare patients who saw Dr. Gergi in 2024. The largest group is 75 to 84, with 127 patients. 69% of them have high blood pressure, and 66% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gergi's median patient age at 75, with 45% women.

In 2024, Dr. Gergi wrote 731 Medicare Part D claims for 85 patients. 76% of them were for generic drugs. CMS names the drug for 550 of them, across 17 drugs with 11 or more claims each, at $1,070,821 in total drug cost. In 2023, CMS named 304 claims across 11 drugs.

Dr. Gergi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gergi as offering telehealth.

Dmand AI links 12 papers to Dr. Gergi, published from 2020 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Hemostasis. Dr. Gergi has published most often in Res Pract Thromb Haemost. Dr. Gergi's most frequent co-authors are Neil Adrian Zakai, MD, Hanny Toban Al-Samkari, MD and Christos Colovos, MD, PhD.

CMS Open Payments shows 23 general payments to Dr. Gergi from 7 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 91% of the total. Janssen Pharmaceuticals, Inc paid the most, $343.

Dr. Gergi graduated from Lebanese University School of Medicine in 2015.